Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: A prospective and observational multicenter study

Critical Care

Volumn 15, Issue 1, 2011, Pages

  Magret, Mònica ^a   Lisboa, Thiago ^b   Martin Loeches, Ignacio ^c   Máñez, Rafael ^d   Nauwynck, Marc ^e   Wrigge, Hermann ^f   Cardellino, Silvano ^g   Díaz, Emili ^b   Koulenti, Despina ^h   Rello, Jordi ⁱ  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^c MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e General Hospital St Jan   (Belgium)

^f UNIVERSITY HOSPITAL BONN   (Germany)

^g Cardinal Massaia Hospital   (Italy)

^h NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

ⁱ HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HYPERTENSIVE AGENT;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIC NOSOCOMIAL PNEUMONIA; BACTERIAL PNEUMONIA; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DIAGNOSTIC TEST; ENDOTRACHEAL INTUBATION; EUROPE; FEMALE; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL ADMISSION; HOSPITAL ASSOCIATED PNEUMONIA; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; MULTICENTER STUDY; NONBACTEREMIC NOSOCOMIAL PNEUMONIA; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; RISK FACTOR; SIMPLIFIED ACUTE PHYSIOLOGY SCORE II; SURGICAL PATIENT; VENTILATOR ASSOCIATED PNEUMONIA; BACTEREMIA; CLINICAL TRIAL; CROSS INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA; PROGNOSIS; STATISTICS; TIME; TREATMENT OUTCOME;

ACINETOBACTER BAUMANNII; AGED; BACTEREMIA; CROSS INFECTION; EUROPE; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PNEUMONIA; PNEUMONIA, BACTERIAL; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79951553248     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10036     Document Type: Article

References (36)

1. Rello J, Mirelis B, Alonso C, Prats G. Lack of usefulness of blood cultures to diagnose ventilator-associated pneumonia. Eur Respir J 1991, 4:1020.
2. Rello J, Gallego M, Mariscal D, Soñora R, Valles J. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 1997, 156:196-200.
3. Luna CM, Videla A, Mattera J, Vay C, Famiglietti A, Vujacich P, Niederman MS. Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in ventilator-associated pneumonia. Chest 1999, 116:1075-1084. 10.1378/chest.116.4.1075, 10531175.
4. DeRyke CA, Lodise TP, Rybak MJ, McKinnon PS. Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia. Chest 2005, 128:1414-1422. 10.1378/chest.128.3.1414, 16162737.
5. Gonzalez C, Rubio M, Romero-Vivas J, González M, Picazo JJ. Staphylococcus aureus bacteremic pneumonia: differences between community and nosocomial acquisition. Int J Infect Dis 2003, 7:102-108. 10.1016/S1201-9712(03)90004-X, 12839710.
6. Agbaht K, Diaz E, Muñoz E, Lisboa T, Gomez F, Depuydt PO, Blot SI, Rello J. Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: a study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia. Crit Care Med 2007, 35:2064-2070. 10.1097/01.CCM.0000277042.31524.66, 17581489.
7. Kerdudou S, Laschke MW, Sinha B, Preissner KT, Menger MD, Hermann M. Fibronectin binding proteins contribute to the adherence of Staphylococcus aureus to intact endothelium in vivo. Thromb Haemost 2006, 96:183-189.
8. Koulenti D, Lisboa T, Brun-Buisson C, Krueger W, Macor A, Sole-Violan J, Diaz E, Topeli A, DeWaele J, Carneiro A, Martin-Loeches I, Armaganidis A, Rello J, . EU-VAP/CAP Study Group Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med 2009, 37:2360-2368. 10.1097/CCM.0b013e3181a037ac, 19531951, EU-VAP/CAP Study Group.
9. Le Gall JR, Lemeshow S, Saulnier F. A new simplified physiology score (SAPS II) based on a European/North American multicentre study. JAMA 1993, 270:2957-2963. 10.1001/jama.270.24.2957, 8254858.
10. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874. 10.1097/00003246-199206000-00025, 1597042, American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference.
11. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710. 10.1007/BF01709751, 8844239.
12. . American Thoracic Society, Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416. 10.1164/rccm.200405-644ST, 15699079, American Thoracic Society, Infectious Diseases Society of America.
13. Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999, 160:608-613.
14. Taylor GD, Buchanan-Chell M, Kirkland T, McKenzie M, Wiens R. Bacteremic nosocomial pneumonia. A 7-year experience in one institution. Chest 1995, 108:786-788. 10.1378/chest.108.3.786, 7656634.
15. Bryan CS, Reynolds KL. Bacteremic nosocomial pneumonia. Analysis of 172 episodes from a single metropolitan area. Am Rev Respir Dis 1984, 129:668-671.
16. Schultz MJ, Millo J, Levi M, Hack CE, Weverling GJ, Garrard CS, van der Poll T. Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax 2004, 59:130-135. 10.1136/thorax.2003.013888, 1746934, 14760153.
17. Menzies BE. The role of fibronectin binding proteins in the pathogenesis of Staphylococcus aureus infections. Curr Opin Infect Dis 2003, 16:225-229.
18. Cheung AL, Krishnan M, Jaffe EA, Fischetti VA. Fibrinogen acts as a bridging molecule in the adherence of Staphylococcus aureus to cultured human endothelial cells. J Clin Invest 1991, 87:2236-2245. 10.1172/JCI115259, 296985, 1710235.
19. Shinbori T, Walczak H, Krammer PH. Activated T killer cells induce apoptosis in lung epithelial cells and the release of pro-inflammatory cytokine TNF-α. Eur J Immunol 2004, 34:1762-1770. 10.1002/eji.200425097, 15162447.
20. Bachert C, Gevaert P, Zhang N, van Zele T, Perez-Novo C. Role of staphylococcal superantigens in airway disease. Chem Immunol Allergy 2007, 93:214-236. full_text, 17369708.
21. Depuydt PO, Blot SI, Benoit DD, Claeys GW, Verschraegen GL, Vandewoude KH, Vogelaers DP, Decruyenaere JM, Colardyn FA. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit. Crit Care Med 2006, 34:653-659. 10.1097/01.CCM.0000201405.16525.34, 16505649.
22. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993, 94:281-288. 10.1016/0002-9343(93)90060-3, 8452152.
23. Cisneros JM, Rodríguez-Baño J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 2002, 8:687-693. 10.1046/j.1469-0691.2002.00487.x, 12445005, 12445005 .
24. Rodriguez-Baño J, Martí S, Soto S, Fernández-Cuenca F, Cisneros JM, Pachón J, Pascual A, Martínez-Martínez L, McQueary C, Actis LA, Vila J, . Spanish Group for the Study of Nosocomial Infections (GEIH) Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect 2008, 14:276-278. Spanish Group for the Study of Nosocomial Infections (GEIH).
25. Garnacho J, Sole-Violan J, Sa-Borges M, Diaz E, Rello J. Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study. Crit Care Med 2003, 31:2478-2482. 10.1097/01.CCM.0000089936.09573.F3, 14530754.
26. Wareham D, Bean D, Khanna P, Hennessy EM, Krahe D, Ely A, Millar M. Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact if multi-drug resistance. Eur J Clin Microbiol Infect Dis 2008, 27:607-612. 10.1007/s10096-008-0473-y, 18283503.
27. Robenshtok E, Paul M, Leibovici L, Fraser A, Pitlik S, Ostfeld I, Samra Z, Perez S, Lev B, Weinberger M. The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes. J Hosp Infect 2006, 64:282-287. 10.1016/j.jhin.2006.06.025, 16930770.
28. Jamulitrat S, Arunpan P, Phainuphong P. Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection. J Med Assoc Thai 2009, 92:413-419.
29. Trouillet J, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, Gibert C. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998, 157:531-539.
30. Blot S, Depuyct P, Vandewoude K, De Bacquer D. Measuring the impact of multi-drug resistance in nosocomial infection. Curr Opin Infect Dis 2007, 20:391-396. 10.1097/QCO.0b013e32818be6f7, 17609598.
31. Ibrahim EH, Ward S, Sherman G, Kollef MH. A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. Chest 2000, 117:1434-1442. 10.1378/chest.117.5.1434, 10807834, 10807834.
32. Niederman MS. Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit Care Med 2001, 29:N114-N120. 10.1097/00003246-200104001-00011, 11292886, 11292886 .
33. Shorr AF, Tabak YP, Gupta V, Johannes RS, Liu LZ, Kollef MH. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care 2006, 10:R97. 10.1186/cc4946, 1550967, 16808853, 16808853.
34. Menzies BE. The role of fibronectin binding proteins in the pathogenesis of Staphylococcus aureus infections. Curr Opin Infect Dis 2003, 16:225-229.
35. Bodi M, Ardanuy C, Rello J. Impact of Gram-positive resistance on outcome of nosocomial pneumonia. Crit Care Med 2001, 29:N82-N86. 10.1097/00003246-200104001-00005, 11292880, 11292880.
36. Lisboa T, Diaz E, Sa-Borges M, Socias A, Sole-Violan J, Rodríguez A, Rello J. The ventilator-associated pneumonia PIRO score: a tool for predicting ICU mortality and health-care resources use in ventilator-associated pneumonia. Chest 2008, 134:1208-1216. 10.1378/chest.08-1106, 18779186.